| 摘要 |
The present invention relates to tolerogenic cells for use in preventing or reducing graft rejection in a subject, wherein said graft is non-syngeneic with the subject and said tolerogenic cells are CD4+CD25+ cells, and wherein said tolerogenic cells are non-syngeneic with both the subject and the graft. |
